Moreover, other groups have already published pre-clinical studies on the efficacy of anti-EGFR antibodies conjugated with NIR-Dye (including IRDye® 800CW) in detecting lung cancer in both in-vitro and in-vivo settings [23]. The gene discussed is EGFR; the disease is lung carcinoma.